A novel anti-ischemic stroke candidate drug AAPB with dual effects of neuroprotection and cerebral blood flow improvement
Ischemic stroke (IS) is a globally life-threatening disease. Presently, few therapeutic medicines are available for treating IS, and rt-PA is the only drug approved by the US Food and Drug Administration (FDA) in the US. In fact, many agents showing excellent neuroprotection but no blood flow-improv...
Saved in:
| Main Authors: | Jianbing Wu, Duorui Ji, Weijie Jiao, Jian Jia, Jiayi Zhu, Taijun Hang, Xijing Chen, Yang Ding, Yuwen Xu, Xinglong Chang, Liang Li, Qiu Liu, Yumei Cao, Yan Zhong, Xia Sun, Qingming Guo, Tuanjie Wang, Zhenzhong Wang, Ya Ling, Wei Xiao, Zhangjian Huang, Yihua Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525000048 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From S-nitrosation targets to drugs: A potential new paradigm in disease treatment
by: Hui Ye, et al.
Published: (2025-08-01) -
A Fluorescent Probe for Imaging and Treating S-Nitrosation Stress in OGD/R Cells
by: Hui Ye, et al.
Published: (2025-03-01) -
2024 international conference on neuroprotective agents conference proceedings
by: William Slikker, et al.
Published: (2025-07-01) -
Neuroprotection, excitotoxicicity and nmda antagonists
by: RUBENS JOSÉ GAGLIARDI
Published: (2000-06-01) -
Peculiarities of neuroprotective therapy in women with acute ischemic stroke
by: O. A. Halushko, et al.
Published: (2020-08-01)